日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Chimeric Antigen Receptor (CAR)-NK92 cells effective against glioblastoma, breast- and pancreatic cancer in vitro and in a murine xenograft model of ovarian cancer

嵌合抗原受体(CAR)-NK92细胞在体外和卵巢癌小鼠异种移植模型中均对胶质母细胞瘤、乳腺癌和胰腺癌有效。

Boulifa, Abdelhadi; Franzén, Alexander Sebastian; Raftery, Martin J; Radecke, Clarissa; Pecher, Gabriele

Reduction of Prostate Cancer Risk: Role of Frequent Ejaculation-Associated Mechanisms

降低前列腺癌风险:频繁射精相关机制的作用

Hassan, Mohamed; Flanagan, Thomas W; Eshaq, Abdulaziz M; Altamimi, Osama K; Altalag, Hassan; Alsharif, Mohamed; Alshammari, Nouf; Alkhalidi, Tamadhir; Boulifa, Abdelhadi; El Jamal, Siraj M; Haikel, Youssef; Megahed, Mossad

Role of beta-(1→3)(1→6)-D-glucan derived from yeast on natural killer (NK) cells and breast cancer cell lines in 2D and 3D cultures

酵母来源的 β-(1→3)(1→6)-D-葡聚糖在 2D 和 3D 培养中对自然杀伤 (NK) 细胞和乳腺癌细胞系的作用

Abdelhadi Boulifa, Martin J Raftery, Alexander Sebastian Franzén, Clarissa Radecke, Sebastian Stintzing, Jens-Uwe Blohmer, Gabriele Pecher

Next-Generation CEA-CAR-NK-92 Cells against Solid Tumors: Overcoming Tumor Microenvironment Challenges in Colorectal Cancer

新一代 CEA-CAR-NK-92 细胞对抗实体瘤:克服结直肠癌的肿瘤微环境挑战

Alexander Sebastian Franzén, Abdelhadi Boulifa, Clarissa Radecke, Sebastian Stintzing, Martin J Raftery, Gabriele Pecher

Next Generation CD44v6-Specific CAR-NK Cells Effective against Triple Negative Breast Cancer

下一代 CD44v6 特异性 CAR-NK 细胞可有效治疗三阴性乳腺癌

Martin J Raftery, Alexander Sebastian Franzén, Clarissa Radecke, Abdelhadi Boulifa, Günther Schönrich, Sebastian Stintzing, Jens-Uwe Blohmer, Gabriele Pecher